Li Yan

Li Yan is a seasoned professional in clinical pharmacology and drug metabolism and pharmacokinetics (DMPK) with extensive experience in leading high-performing teams and managing clinical pharmacology-related activities across various therapeutic areas. Currently serving as Senior Director and Head of Clinical Pharmacology at Spyre Therapeutics since May 2024 and as an Adjunct Professor at the University of the Pacific, Li Yan previously held key leadership roles at NGM Biopharmaceuticals, Horizon, Viela Bio, AstraZeneca, Certara, and UCSF. Educational qualifications include PhDs in Bioengineering from the University of California, San Francisco, and the University of California, Berkeley, along with an MS in Molecular, Cellular & Developmental Biology from the University of Colorado Boulder and a BS in Molecular Biology from Jilin University.